Research Grant Recipients

Year	Recipient	Institution/Location	Amount	Grant Research Project Title
1997	Dr. Michael Marmor	Stanford University	$ 7,000	Visual prognosis of retinal artery occlusion, a retinal vascular disease which can cause profound visual loss
	Dr. Robert Nussenblatt	National Institutes of Health	$ 7,000	Rare condition called serpiginous choroiditis
1998	Stuart L. Fine, MD	Scheie Eye Institute, Philadelphia, PA	$ 7,000	Prevalence of Signs of Early Choroidal Neovascularization in Indocyanine Angiography Among Patients with Bilateral Macular Drusen
	August Deutman, MD	University of Njimegen, The Netherlands	$ 7,000	Linkage Study in Benign Concentric Annular Macular Dystrophy (BCAMD)
	Robert Flower, MD	Glaser Murphy Ret.Tr. Ctr, Towson, MD	$ 7,000	Improved Identification of Photocagulation Treatable CNV Feeder Vessels
	Gerald Fishman, MD	Chicago, IL	$ 7,000	Animal Model for Juvenile Macular Degeneration due to a Mutation in Peripherin/rds Gene
1999	Lawrence S. Morse, MD	University of California Davis, Sacramento, CA	$ 7,000	Ceremide Mediated Signal Transduction of Apoptosis Following Laser Photocoagulation of RPE Cells
	Joan W. Miller, MD	Mass. Eye & Ear Infirmary, Boston, MA	$ 7,000	Combined Effects of Angiostatin and Photodynamic Therapy for Choroidal Neovascularization Treatment
	Carmen A. Puliafito, MD	New England Eye Center, Boston, MA	$ 7,000	Mechanistic Selection of Neuroprorectiive Retinal Agents
	Julia Haller, MD	Wilmer Institute, Baltimore, MD	$ 7,000	Trail of Sandostatin to Treat Cystoid Macular Edema
2000	Jerry Shields, MD	Wills Eye Hospital, Philadelphia, PA	$ 10,000	Retinal Capillary Hemangioma Phenotypic Variability, Progression, Treatment and Visual Outcome
	Paul Sternberg, Jr. MD	Emory Eye Center, Atlanta, GA	$ 10,000	Smoking Redox Status, and Age-Related Macular Degeneration
	John Marshall, MD	The Rayne Institute, London, England	$ 10,000	Establishment of an in vitro reconstituted RPE-Bruch's membrane complex as a model for aging and AMD
	Timothy Murray, MD	Bascom Palmer Eye Institute, Miami, FL	$ 10,000	Globe-conserving (salvage) Therapy in the Management of Macula Transgenic Retinoblastoma: Role of Apoptotic Activation
2001	Lucian Del Priore, MD	Columbia University	$ 10,000	Changes in Gene Expression of RPE Seeded onto AMD Bruch's Membrane
	Marco Zarbin, MD	New Jersey Medical School	$ 10,000	Cell-ECM Adhesion Molecule Expression in Human Neonatal RPE
2002	Nancy Holekamp, MD	Barnes Retina Institute	$ 10,000	The Use of Anti-PEDF to Create an Animal Model of AMD
	Lee Jampol, MD	Northwestern University	$ 5,000	Database of White Dot Syndromes of the Eye
	Joan O'Brien, MD	University of California	$ 9,650	Evaluation of the effects of the PARP-inhibitors, INH2BP and NO2BA, and the tubulin inhibitor, DIPE, in murine retionblastoma
	Marco Zarbin, MD	New Jersey Medical School	$ 3,000	Aged human RPE spreading and migration on ECM ligands
	Gregg Kokame, MD	The Retina Center at Pali Momi	$ 2,500	Choroidal Neovascularization and the Efficacy of Photodynamic Therapy in Asian Patients with Age Related Macular Degeneration
	David H. Orth, MD	Illinois Retina Associates	$ 3,000	Intravitreal Steroid Injection Study Trials
	Tom Chang, MD	Doheny Retinal Institute	$ 3,000	Comparative Outcomes Study in Age Related Macular Degeneration
	Don Weinberger, MD	Petach-Tiqua, Isreal	$ 3,000	Inhibitation of retinal neorvascularization by hypecia
2003	M. Elizabeth Hartnett, MD	University of North Carolina	$ 10,000	The Role of cell-associated VEGF isoforms in endothelial cell transmigration across the retinal pigment epithelium
	J. William Harbour, MD	Washington University	$ 10,000	Molecular prognostic assay for uveal melanoma
	Anat Loewenstein, MD	Tel Aviv Souraski Medical Ctr	$ 8,000	Visual Cortex mapping in age related macular degeration -an fMRI study
	Lawrence Morse, MD	University of CA at Davis	$ 6,000	High fat diet as an independent risk factor for severity of choroidal neorvasculariation in an experimental mouse model
	Neil Bressler, MD	Wilmer Eye Institute	$ 6,000	Subclinical diabetic macular edema:a natural history study
2004	Muna Naash, MD	Univ. of Oklahoma HSC	$ 10,000	Non-viral gene therapy to rescue a mouse model of macular dystrophy
	Andrew Lotery, MD	Southhampton Gen. Hosp. (Southhampton, UK)	$ 10,000	Genotype phenotype correlations in fibulin 5 related age-related macular degeneration and cutis laxa
	Dov Weinberger, MD	Beilinson Hospital (Petach Tiqua, Isreal)	$ 7,000	Intravitreal injection of bone marrow derived stem cells after laser treatment to central retina
	William Mieler, MD	University of Chicago	$ 5,000	Evaluation of release kinetics of PLGA microspheres for Gatifloxacin 0.3% or
2005	Paul S.Bernstein, MD	John Moran Eye Center (Salt Lake City, UT)	$ 9,000	Clinical interventions against Stargardt Macular Dyst Phase I pilot Study of 4_MP as an inhibitor to Dark Adaption
	Ian M. MacDonald, MD	Royal Alexandra Hospital (Alberta, Canada)	$ 7,500	Visual field defects in a mouse model of geographic atrophy
	Jennifer I. Lim, MD	Doheny Eye Institute (Los Angeles, CA)	$ 7,500	Determination of Hypoxic Inducible Factor 1 in Preretinal Diabetic Membrances
	Jorge G.Arroyo, MD	Beth Israel Deaconess Med Center (Boston, MA)	$ 7,500	Vitreous and serum concentrations of triamcinoclone acetonide after peribulbar injection
2006	James Handa, MD	Johns Hopkins Hospital (Baltimore, MD)	$ 10,000	Efficacy of Intravitreally Delivered Nonsteroidal Anti-Inflammatory Drugs
	Robyn Guymer, MD	University of Melbourne (Victoria, Australia)	$ 10,000	Urine Proteomics and Age-Related Macular Degeneration
2007	Paul Sternberg, MD	Vanderbilt University (Nashville, TN)	$ 20,000	Plasma proinflammatory biomarkers in patients with age-related macular degeneration
	Jose Pulido, MD	Mayo Clinic (Rochester, MN)	$ 15,000	Activation State fo Immune Cells in the Human Choriod
2008	Lloyd P. Aiello, MD	Joslin Diabetes Center (Boston, MA)	$ 30,000	Treatment with Oral Rosiglitazone to Prevent the Progression of Diabetic Retinopathy in eyes at high risk of developing proliferative disease
2009	Rajendra S. Apte, MD, PhD	Washington University School of Medicine (St. Louis, MO)	$ 20,000	Wnt Signaling in Choroidal Neovascularization
2010	J. William Harbour, MD	Washington University School of Medicine (St. Louis, MO)	$ 30,000	Development of a blood test to diagnose uveal melanoma
2011	Stephen Tsang, MD, PhD	Columbia University (New York, NY)	$ 20,000	Genetic and Environmental Factors in AMD
	Stephen Jae Kim, MD	Vanderbilt University (Nashville, TN)	$ 20,000	Safety, Pharmacokinetics, and Efficacy of Celecoxib and Valdecoxib after Intraocular Administration for Macular Edema
2012	Kang Zhang, MD	University of California at San Diego School of Medicine and VASDHS	$ 30,000	Using AMD Patient iPSCs for RPE Differentiation and Disease Modeling
	Amani Fawzi, M.D	Northwestern University, Feinberg School of Medicine	$ 15,000	Platform for long-term Delivery of Anti-Angiogenic Peptides for Intravitreal Treatment of Neovascular Eye Disease
	Milam A. Brantley, Jr., M.D., PhD.	Vanderbilt Eye Institute (Nashville, TN)	$ 15,000	Small molecule-mediated differential expression of HTRA1 and ARMS2 to elucidate gene function in AMD
2013	Demetrios Vavvas, MD	Massachusettes Eye and Ear Infirmary (Boston, MA)	$ 30,000	“Role of RIP3 Kinase in Inflammation and Photoreceptor Cell Loss”
2014-2015	Robyn Heather Guymer, MD	University of Melbourne (East Melbourne, Australia)	$ 30,000	The role of reduced phagocytosis in the pathogenesis of AMD
2015-2016	Christine A. Curcio PhD FARVO	The University of Alabama at Birmingham (Birmingham, AL)	$ 30,000	Visualizing organelles in human retinal pigment epithelium by 3-dimensional electron microscopy
2016-2017	Mary Elizabeth Hartnett, MD, FACS, FARVO	Moran Eye Center, University of Utah	$ 30,000	Novel Gene Therapy to Regulate Pathologic Neovascularization in AMD
2017-2018	Cagri G. Besirli. MD, PhD	University of Michigan	$ 30,000	The role of HK2 in photoreceptor metabolism and survival
	Shlomit Schaal, MD	UMASS medical school	$ 37,500	Cone photoreceptor defects in retinal degenerative diseases
	Naresh Mandava, MD	University of Colorado Denver	$ 37,500	Protein Biomarkers and Biological Pathways in the Reticular Pseudodrusen Phenotype of Age-Related Macular Degeneration
2018-2019	Stephen Yeh, MD	Emory Eye Center	$ 30,000	Ophthalmic Surveillance of Emerging Infectious Diseases within Sub-Saharan African and Southeast Asian Outbreak Zones
	R. Theodore Smith, MD	Icahn School of Medicine at Mount Sinai (New York Eye and Ear Infirmary of Mount Sinai)	$ 37,500	Fluorescence lifetime imaging in Age-related macular degeneration (AMD)
	Glenn Yiu, MD	UC Davis Health	$ 37,500	Host immune responses to CRISPR-based Genome Editing of VEGF-A using AAV vectors
2019-2020	Kathryn Pepple, MD	University of Washington	$ 30,000	Retinal microglia and innate lymphoid cells in post-infectious uveitis
	Deeba Husain, MD	Mass Eye and Ear, Harvard Medical School	$ 37,500	Role of tissue metabolomics in Age related Macular Degeneration
	Jasmine Francis, MD	Memorial Sloan Kettering Cancer Center	$ 37,500	Noninvasive Molecular Profiling of Uveal Melanoma with Cell-free DNA Analysis
2020-2021	Prithvi Mruthyunjaya, MD	Byers Eye Institute at Stanford University	$ 30,000	Aqueous Humor Proteomic analysis to detect targetable diagnostic biomarkers in uveal melanoma
2021-2022	Abigail Fahim, MD	University of Michigan	$ 30,000	Effects of PRDM13 pathogenic variants on retinal pigment epithelium differentiation in North Carolina Macular Dystrophy
	Ajay E. Kuriyan, MD, MS	Wills Eye Hospital	$ 30,000	Investigating the Role of Monocarboxylate Transporter 4 (MCT4) and Lactate in Proliferative Vitreoretinopathy
2022-2023

Forgot Login?

Officers (2025-2026)

President:

Julia A. Haller, MD

Executive Secretary and Founder:

Lawrence J. Singerman, MD

President-Elect:

Judy E. Kim, MD

Secretary:

Richard F. Spaide, MD Treasurer: Mary Elizabeth R. Hartnett, MD

Committee Chairs

Awards:

Daniel F. Martin, MD

By-Laws:

Anita Agarwal, MD

Credentials:

Manjot K. Gill, MD

Endowment Committee:

Daniel F. Martin, MD
Meeting Planning:

William F. Mieler, MD, FACS, FARVO

Nominating:

Ivana K. Kim, MD

Program:

David Sarraf, MD

Research:

Amani Fawzi, MD

Website:

Dilraj S. Grewal, MD

International Membership:

Gemmy Cheung, MD

Young Member Representative:

Katherine E. Talcott, MD

AAO Representative:

Sunir J. Garg, MD, FACS

Past Presidents

Arnall Patz, MD

J. Donald M. Gass, MD

Morton F. Goldberg, MD

Robert C. Watzke, MD

Stephen J. Ryan, MD

John G. Clarkson, MD

David H. Orth, MD

Alexander J. Brucker, MD

Lee M. Jampol, MD

Thomas M. Aaberg, MD

Travis A. Meredith, MD

Kurt A. Gitter, MD

William F. Mieler, MD

Daniel Finkelstein, MD

Lawrence A. Yannuzzi, MD

Evangelos S. Gragoudas, MD

Jerry A. Shields, MD

Michael L. Klein, MD

Emily Y. Chew, MD

Mark S. Blumenkranz, MD

Neil M. Bressler, MD

Paul Sternberg, Jr., MD

M. Gilbert Grand, MD

Andrew P. Schachat, MD

James C. Folk, MD

H. Richard McDonald, MD

Joan W. Miller, MD

Carol L. Shields, MD
Mark W. Johnson, MD
Glenn J. Jaffe, MD
Daniel F. Martin, MD
Immediate Past President
SriniVas R. Sadda, MD

Conference Management Software by X-CD Technologies Inc.

Reset Password